Paul Bolno
Known title: President and CEOCIK: 0001657710
Associated companies
Transaction History
| WVE | ▼ Sell | Open Market | 10,480 | $141K | 2/9/2026 | View on chart |
| WVE | ▲ Buy | Grant | 165,000 | $0 | 2/5/2026 | View on chart |
| WVE | ▼ Sell | Open Market | 217,351 | $2.2M | 8/22/2025 | View on chart |
| WVE | ▲ Buy | Option Exercise | 169,025 | $419K | 3/7/2025 | View on chart |
| WVE | ▼ Sell | Open Market | 169,025 | $1.6M | 3/7/2025 | View on chart |
| WVE | ▲ Buy | Grant | 121,000 | $0 | 2/4/2025 | View on chart |
| WVE | ▲ Buy | Option Exercise | 50,000 | $124K | 11/25/2024 | View on chart |
| WVE | ▼ Sell | Open Market | 50,000 | $750K | 11/25/2024 | View on chart |
| WVE | ▼ Sell | Open Market | 51,234 | $734K | 11/15/2024 | View on chart |
| WVE | ▼ Sell | Open Market | 90,474 | $1.4M | 10/16/2024 | View on chart |
| WVE | ▼ Sell | Open Market | 48,366 | $280K | 8/21/2024 | View on chart |
| WVE | ▼ Sell | Open Market | 29,400 | $119K | 2/16/2023 | View on chart |
| WVE | ▼ Sell | Open Market | 33,501 | $58K | 5/5/2022 | View on chart |
| WVE | ▲ Buy | Grant | 92,500 | $0 | 5/4/2022 | View on chart |
| WVE | ▼ Sell | Open Market | 33,150 | $77K | 2/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Wave Life Sciences to Present at Chardan Healthcare Conference
Wave Life Sciences announced it will present at Chardan’s 10th Annual Healthcare Conference. The presentation offers a chance to discuss recent developments and pipeline progress with investors and industry peers. This exposure arrives while the stock is near a key support level, and observers may look for any new information that could affect sentiment.
Wave Life Sciences to Present at Chardan Healthcare Conference. Wave Life Sciences announced it will present at Chardan’s 10th Annual Healthcare Conference. The presentation offers a chance to discuss recent developments and pipeline progress with investors and industry peers. This exposure arrives while the stock is near a key support level, and observers may look for any new information that could affect sentiment.